Rilematovir

DB15672InvestigationalSmall molecule

Rilematovir is under investigation in clinical trial NCT04056611 (Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial...

Formula / weight: C₂₁H₂₀ClF₃N₄O₃S · 500.92 g/mol (avg)
Code names: JNJ-53718678

Resolves to

Compound

UNIINQ99E8OH3PCAS1383450-81-4

Structure

InChIKeyGTQTUABHRCWVLL-UHFFFAOYSA-NSMILESCS(=O)(=O)CCCN1C(CN2C(=O)N(CC(F)(F)F)C3=C2C=NC=C3)=CC2=C1C=CC(Cl)=C2

Targets

P03420F

What you can answer from here — as of September 26, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Rilematovir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account